Exclusive:Anti aging and health of the elderly

Application value of Chinese medicine in postoperative treatment of perimenopausal endometriosis

  • ZHENG Juan ,
  • HAN Ying ,
  • WANG Danning ,
  • WU Dan ,
  • CONG Huifang
Expand
  • 1. Graduate School, Heilongjiang University of Chinese Medicine, Harbin 150000, China;
    2. Department of Gynecology, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine, Harbin 150001, China

Received date: 2024-02-21

  Revised date: 2024-06-21

  Online published: 2024-12-26

Abstract

The incidence of endometriosis (EMS) in perimenopausal women is relatively higher and can undergo malignant transformation with age, requiring surgical treatment. Perimenopausal EMS patients are prone to postoperative Qi and blood deficiency, leading to recurrence, perimenopausal syndrome, poor surgical incision healing, and other complications, which are harmful to overall recovery. This article reviews the application value and potential mechanisms of Chinese medicine in postoperative treatment of perimenopausal EMS patients. It is found that the postoperative application of internal and external therapies of Chinese medicine for perimenopausal EMS can achieve both internal and external outcomes based on syndrome differentiation and staging. With pathogenesis of EMS, clinical manifestations of perimenopause, and adverse effects of surgical trauma being taken into consideration, it can reduce recurrence rate, relieve perimenopausal symptoms, enhance therapeutic effect, promote patient recovery, and accelerate wound healing, which has proved its clinical promotion value.

Cite this article

ZHENG Juan , HAN Ying , WANG Danning , WU Dan , CONG Huifang . Application value of Chinese medicine in postoperative treatment of perimenopausal endometriosis[J]. Science & Technology Review, 2024 , 42(22) : 70 -75 . DOI: 10.3981/j.issn.1000-7857.2024.06.00630

References

[1] 韩晓佳, 孔宪超, 陈冲, 等. 子宫内膜异位症的临床诊断及治疗新进展[J]. 现代生物医学进展, 2013, 13(2): 388-391.
[2] Haas D, Chvatal R, Reichert B, et al. Endometriosis: A premenopausal disease? Age pattern in 42079 patients with endometriosis[J]. Archives of Gynecology and Obstetrics, 2012, 286(3): 667-670.
[3] Torng P L. Clinical implication for endometriosis associated with ovarian cancer[J]. Gynecology and Minimally Invasive Therapy, 2017, 6(4): 152-156.
[4] 何政星, 王姝, 冷金花, 等. 子宫内膜异位症恶变的临床风险分析[J]. 中华妇产科杂志, 2018, 53(4): 282-284.
[5] 王媛媛, 李颖颖, 常丰华, 等. 围绝经期卵巢型子宫内膜异位症恶变风险预测模型的建立及评估[J]. 中国妇幼健康研究, 2024, 35(2): 44-51.
[6] 王媛媛, 李颖颖, 常丰华, 等. 围绝经期子宫内膜异位症恶变风险预测列线图的建立[J]. 郑州大学学报(医学版), 2023, 58(3): 394-398.
[7] 陈可冀, 史载祥. 实用血瘀证学[M]. 北京: 人民卫生出版社, 1999.
[8] 石举梅, 孙文杰, 李寒宇, 等. 赵瑞华从肝脾肾论治围绝经期子宫内膜异位症经验[J]. 湖北中医药大学学报, 2021, 23(6): 113-116.
[9] 崔轶凡, 刘宏奇. 基于子宫内膜异位症与恶性肿瘤的相关性探析补肾化瘀法作用机制及中医理论依据[J]. 世界科学技术-中医药现代化, 2020, 22(2): 441-445.
[10] 陈彩江, 韩玉斌. 腹腔镜术后联合中药治疗子宫内膜异位症的效果及对妊娠结局的影响[J]. 中国医学创新, 2020, 17(12): 138-141.
[11] Ormston T, Dalton R, Stewart B T. How to do a structured rectal mobilization in complex pelvic endometriosis [J]. ANZ Journal of Surgery, 2018, 88(4): 374-375.
[12] 梁炎春, 曾伟婷, 吴锦杰, 等. HMGB1在子宫内膜异位症神经病理性疼痛中的作用[J]. 中华妇产科杂志, 2018, 53(2): 135-138.
[13] Vercellini P, Buggio L, Borghi A, et al. Medical treatment in the management of deep endometriosis infiltrating the proximal rectum and sigmoid colon: A comprehensive literature review[J]. Acta Obstetricia et Gynecologica Scandinavica, 2018, 97(8): 942-955.
[14] 黄月娇. 子宫内膜异位症腹腔镜术后不同药物治疗临床效果比较[J]. 中外医学研究, 2017, 15(35): 15-16.
[15] 黄飞翔, 丁渊. 中药二联疗法联合GnRHa治疗腹腔镜术后子宫内膜异位症的疗效观察[J]. 上海中医药杂志, 2020, 54(3): 76-81.
[16] 周艳艳. 补肾活血法对EMs大鼠模型细胞因子的影响[J]. 河南中医学院学报, 2008, 23(1): 35-36.
[17] 张春青. 中药周期调治法防治子宫内膜异位症术后复发的临床观察[J]. 贵阳中医学院学报, 2013, 35(1): 159-160.
[18] 谢琼. 中药周期疗法治疗子宫内膜异位症术后30例临床观察[J]. 江苏中医药, 2014, 46(1): 40-41.
[19] 刘欣鑫. 自拟消异方联合曼月乐用于中重度子宫内膜异位症术后治疗的临床研究[J]. 中国现代医生, 2013, 51(31): 104-106.
[20] 刘丽英, 盖赵秀, 姚海东, 等. 中药化癥汤联合红外线照射预防重症子宫内膜异位症术后复发的疗效观察[J]. 齐齐哈尔医学院学报, 2013, 34(23): 3484-3485.
[21] 吕银娟, 张智华, 吴建红. 从四神丸探析脾阳根于肾阳[J]. 中医研究, 2012, 25(5): 10-12.
[22] 夏爱军, 韩克, 翁时秋. 益肾宁坤方治疗醋酸亮丙瑞林所致围绝经期症状的临床研究[J]. 环球中医药, 2014, 7(10): 792-794.
[23] 李瑄, 叶敦敏. 清热凉血散瘀法治疗长效GnRh-α降调节不良反应的临床观察[J]. 光明中医, 2019, 34(12): 1838-1840.
[24] 朱利, 成臣, 罗梅, 等.“滋肾宁心汤”对子宫内膜异位症术后患者应用GnRH-a致类绝经期症状的影响: 附30例临床资料[J]. 江苏中医药, 2016, 48(10): 86-89.
[25] 俞传江, 史晨. 坤泰胶囊与戊酸雌二醇片治疗子宫内膜异位症术后加用GnRH-a致围绝经期症状的临床效果比较[J]. 临床合理用药, 2023, 16(16): 89-92.
[26] 杜晓琴, 衡明莉, 徐玲. 坤泰胶囊和激素替代治疗围绝经期综合征患者的有效性及安全性荟萃分析[J]. 国际妇产科学杂志, 2016, 43(3): 267-271.
[27] Sun X L, Wang X, Zhao Z Y, et al. Paeoniflorin accelerates foot wound healing in diabetic rats though activating the Nrf2 pathway[J]. Acta Histochemica, 2020, 122(8): 151649.
[28] 王洪波. 桂枝龙骨牡蛎汤治疗围绝经期烘热汗出心悸心烦失眠38例临床观察[J]. 世界最新医学信息文摘, 2018, 18(77): 174-175.
[29] 宋彩红, 侯凤艳, 王涛. 桂枝加龙骨牡蛎汤治疗2型糖尿病并焦虑状态的分析[J]. 现代医学与健康研究电子杂志, 2018, 2(19): 165, 167.
[30] 阙华发, 朱元颖, 王云飞, 等. 益气化瘀中药对糖尿病皮肤溃疡大鼠缺氧诱导因子-1α和血管内皮细胞生长因子的影响[J]. 中西医结合学报, 2007, 5(2): 165-169.
[31] 王玲玲, 安丽娅. 熏蒸疗法对妇科术后伤口愈合的影响[J]. 陕西中医, 2014, 35(7): 800-801.
[32] 高翔, 洪利凯, 沈薇, 等. 基于PI3K/Akt信号轴探究三石生新膏对大鼠压疮面愈合的影响[J]. 中国药理学通报, 2021, 37(9): 1299-1304.
[33] 秦伟丽. 中药外敷联合微波理疗在妇科腹部手术切口愈合不良中的应用效果[J]. 内蒙古中医药, 2014, 33(17): 20-21.
[34] Mijaljica D, Spada F, Klionsky D J, et al. Autophagy is the key to making chronic wounds acute in skin wound healing[J]. Autophagy, 2023, 19(9): 2578-2584.
[35] Shakhakarmi K, Seo J E, Lamichhane S, et al. EGF, a veteran of wound healing: Highlights on its mode of action, clinical applications with focus on wound treatment, and recent drug delivery strategies[J]. Archives of Pharmacal Research, 2023, 46(4): 299-322.
[36] 章霞, 汪辉, 刘涟. 中药熏洗治疗妇科术后感染65例 [J]. 河南中医, 2015, 35(6): 1371-1373.
[37] 蒋晓蕾, 朱立宏. 复方黄柏液激活Notch1/Twist1轴对皮肤溃疡大鼠伤口愈合的影响[J]. 中国免疫学杂志, 2023, 39(12): 2560-2565.
[38] 徐磊, 樊炜静, 王徐红, 等. 复方黄柏液中医外治溻渍法治疗Wagner1~2级糖尿病足的临床观察[J]. 中国实验方剂学杂志, 2023, 29(6): 104-110.
Outlines

/